Innovative Medical AI & FHIR-Native Cancer Registry Technology.
Our foundation is built on deep expertise.
Our founders spent years at IBM Watson, and that legacy is reflected in our sophisticated approach to medical AI. We don’t just use AI; we build medical language models and extend existing medical ontologies to solve the unique challenges of oncology data.
While the UMLS (Unified Medical Language System) is a foundational tool with over 130 source vocabularies, its internal inconsistencies often lead to data gaps. NeuralFrame provides a more rigorous solution. By labeling unstructured medical text with precision, we’ve developed a unique Knowledge Iteration Engine and domain-specific CORE Models. These innovations go beyond traditional medical NLP (Natural Language Processing) to deliver unmatched accuracy.
As we ingest more data, our medical AI becomes increasingly powerful, utilizing both explicit and implicit feedback. Our expert-weighted knowledge graphs and state-of-the-art language models allow for rapid adaptation, keeping NeuralFrame at the cutting edge of oncology AI innovation..
This may all sound great, but what does it mean in the real world? Well, here’s a for-instance: When we analyze usage statistics from our industry-leading cancer registry product, KACI, we find the following time savings for ODS’s in abstracting cases from the EMR:
